Adc Therapeutics

(NYSE) ADCT

Current Price$3.83

Market Cap$487.14M

Since IPO (2020)-87%

5 Year-84%

1 Year+168%

1 Month+1%

Adc Therapeutics Financials at a Glance

Market Cap

$487.14M

Revenue (TTM)

$81.36M

Net Income (TTM)

$142.62M

EPS (TTM)

$-1.20

P/E Ratio

-3.19

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$3.83

Volume

39,731

Open

$3.78

Price

$3.83

Volume

39,731

Open

$3.78

Previous Close

$3.83

Daily Range

$3.73 - $3.84

52-Week Range

$1.23 - $4.98

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$3.83

Volume

39,731

Open

$3.78

Previous Close

$3.83

Daily Range

$3.73 - $3.84

52-Week Range

$1.23 - $4.98

ADCT News

No articles available.

ADCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adc Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

193

CEO

Ameet Mallik, MBA

Website

www.adctherapeutics.com

Headquarters

Epalinges, 1066, CH

ADCT Financials

Key Financial Metrics (TTM)

Gross Margin

91%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

Return on Capital

-43%

Return on Assets

-44%

Earnings Yield

-31.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$487.14M

Shares Outstanding

127.19M

Volume

39.73K

Avg. Volume

881.99K

Financials (TTM)

Gross Profit

$73.68M

Operating Income

$108.38M

EBITDA

$106.50M

Operating Cash Flow

$141.17M

Capital Expenditure

$264.00K

Free Cash Flow

$141.44M

Cash & ST Invst.

$261.34M

Total Debt

$439.01M

Adc Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$23.06M

+36.4%

Gross Profit

$19.48M

+25.4%

Gross Margin

84.50%

N/A

Market Cap

$487.14M

N/A

Market Cap/Employee

$1.85M

N/A

Employees

263

N/A

Net Income

$6.41M

+79.1%

EBITDA

$11.81M

+37.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$177.67M

-238.9%

Accounts Receivable

$29.12M

+43.3%

Inventory

$4.18M

-77.2%

Long Term Debt

$437.05M

+259.3%

Short Term Debt

$3.00M

+118.8%

Return on Assets

-44.14%

N/A

Return on Invested Capital

-42.84%

N/A

Free Cash Flow

$31.13M

-41.9%

Operating Cash Flow

$31.12M

-42.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$9.09+2.48%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$2.44-1.21%

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.47+4.26%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$4.80+1.69%

LXRXLexicon Pharmaceuticals, Inc.

LXRXLexicon Pharmaceuticals, Inc.$1.63+1.24%

QSIQuantum-Si incorporated

QSIQuantum-Si incorporated$0.96-2.28%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ADCT

What is the current price of Adc Therapeutics?

Adc Therapeutics is trading at $3.83 per share.

What is the 52-week range for Adc Therapeutics?

Over the past 52 weeks, Adc Therapeutics has traded between $1.23 and $4.98.

How much debt does Adc Therapeutics have?

As of the most recent reporting period, Adc Therapeutics reported total debt of $439.55M.

How much cash does Adc Therapeutics have on hand?

Adc Therapeutics reported $261.34M in cash and cash equivalents in its most recent financial results.

What is Adc Therapeutics’s dividend yield?

Adc Therapeutics does not currently have a dividend yield.

Adc Therapeutics

Adc Therapeutics Financials at a Glance

ADCT News

ADCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Adc Therapeutics

ADCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Adc Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ADCT

What is the current price of Adc Therapeutics?

What is the 52-week range for Adc Therapeutics?

How much debt does Adc Therapeutics have?

How much cash does Adc Therapeutics have on hand?

What is Adc Therapeutics’s dividend yield?

Premium Investing Services